Riskpilot← Back to searchSign inGet full accessProTreatment ApS
APSActiveCVR 30586182A.P. Møllers Allé 43CPhysiotherapy activities · NACE 8695Est. 200728 employees
Revenue 2024
DKK 6,8M
-18% vs 2023
EBITDA margin
1.0%
-95% vs 2023
Equity ratio
27.3%
Financial strength
Net profit 2024
DKK -311K
-136% vs 2023
| Revenue | DKK 6,8M | -18% |
| EBITDA | DKK 68K | -95% |
| Net profit | DKK -311K | -136% |
| Total assets | DKK 10M | -20% |
| Equity | DKK 2,7M | -10% |
| Employees | 28 | — |
Legal name
ProTreatment ApS
CVR number
30586182
Legal form
Anpartsselskab
NACE code
8695 · Physiotherapy activities
Founded
1. april 2007
Share capital
DKK 125.000
Employees
28 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den administrerende direktør eller den samlede direktion.
Company purpose
Selskabets formål er at drive fysioterapeutisk klinik og hermed ligestillet virksomhed
Address
A.P. Møllers Allé 43C
Phone
+4598171209
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 1.550 | 2.723 | 2.162 | 3.079 | 3.321 | 3.988 | 5.195 | 7.830 | 8.289 | 6.823 |
| Staff expenses | -1.033 | -1.066 | -829 | -1.220 | -1.451 | -2.086 | -2.312 | -2.310 | -3.789 | -4.985 | -5.712 | -6.811 | -6.755 |
| EBITDA | — | 510 | 514 | 329 | 1.272 | 38 | 767 | 1.011 | -586 | 210 | 2.045 | 1.334 | 68 |
| Depreciation & amort. | -143 | -133 | -41 | -10 | -13 | -13 | -21 | -29 | -25 | -22 | -23 | -22 | -123 |
| EBIT | — | 376 | 472 | 320 | 1.260 | 26 | 746 | 982 | -611 | 188 | 2.021 | 1.312 | -55 |
| Net financials | 0 | -39 | -15 | 6 | 11 | 15 | 24 | 15 | 12 | -31 | 17 | -197 | -343 |
| Profit before tax | — | 337 | 457 | 326 | 1.271 | 41 | 770 | 997 | -599 | 156 | 2.038 | 1.115 | -398 |
| Tax | 10 | 107 | 137 | 98 | 295 | 17 | 179 | 231 | -110 | 38 | 462 | 248 | -88 |
| Net profit | — | 230 | 320 | 228 | 976 | 23 | 591 | 766 | -489 | 118 | 1.576 | 867 | -311 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | -207 | 723 | 829 | 1.134 | 2.295 | 2.732 | 3.493 | 4.010 | 3.799 | 4.595 | 6.308 | 12.434 | 9.960 |
| Equity | — | 190 | 510 | 738 | 1.413 | 937 | 1.528 | 1.704 | 465 | 584 | 2.159 | 3.026 | 2.716 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39 | 141 | 144 | 200 | 3.312 | 2.766 |
| Short-term debt | 0 | 533 | 319 | 396 | 882 | 1.795 | 1.964 | 2.267 | 3.193 | 3.867 | 3.948 | 6.095 | 4.479 |
| Total debt | 0 | 533 | 319 | 396 | 882 | 1.795 | 1.964 | 2.305 | 3.334 | 4.011 | 4.148 | 9.407 | 7.244 |
EBITDA margin
1.0%
This company
15.8%
Market median
-94% vs market
20122024
Equity ratio
27.3%
This company
38.2%
Market median
-29% vs market
20122024
Return on equity
-11.4%
This company
18.4%
Market median
-162% vs market
20122024
Net profit margin
-4.6%
This company
8.1%
Market median
-157% vs market
20122024
Asset turnover
0.69×
This company
1.12×
Market median
-38% vs market
20122024
Debt / equity
2.67×
This company
0.62×
Market median
-331% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AF Management | Management | 2007 | — | — |
AF Founder | Founder | 2007 | — | — |
NS Management | Management | 2018 | — | — |
TJ Chief Executive Officer | Chief Executive Officer | 2011 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
ProTreatment Holding ApS | Company | 100.0% | 100.0% | 2012 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ProTreatment Holding ApS
ProTreatment ApS Board members of ProTreatment ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anders Fäldt | Management | 0 companies |
| Anders Fäldt | Founder | 0 companies |
| Nadia Seistrup | Management | 0 companies |
| Thomas Jørgensen | Chief Executive Officer | 0 companies |